Enhanced exon skipping in the 4CV dystrophic mouse model of muscular dystrophy through refined oligomer design
Page 1 of 1
Enhanced exon skipping in the 4CV dystrophic mouse model of muscular dystrophy through refined oligomer design
Jon Moulton Mon Oct 22, 2012 3:52 pm
Mitrpant C, Fletcher S, Pinniger G, Johnsen R, Kole R, Wilton SD. Enhanced exon skipping in the 4CV dystrophic mouse model of muscular dystrophy through refined oligomer design. Neuromusc Disord. 2012;22(9):858
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 61
Location : Philomath, Oregon, USA -
Similar topics» Exon Skipping Therapy Using Phosphorodiamidate Morpholino Oligomers in the mdx52 Mouse Model of Duchenne Muscular Dystrophy
» Peptide-conjugated phosphodiamidate oligomer-mediated exon skipping has benefits for cardiac function in mdx and Cmah-/-mdx mouse models of Duchenne muscular dystrophy
» In silico screening based on predictive algorithms as a design tool for exon skipping oligonucleotides in duchenne muscular dystrophy
» Exon Skipping Quantification by qRT-PCR in Duchenne Muscular Dystrophy Patients Treated with the Antisense Oligomer Eteplirsen
» Implications for Cardiac Function Following Rescue of the Dystrophic Diaphragm in a Mouse Model of Duchenne Muscular Dystrophy
» Peptide-conjugated phosphodiamidate oligomer-mediated exon skipping has benefits for cardiac function in mdx and Cmah-/-mdx mouse models of Duchenne muscular dystrophy
» In silico screening based on predictive algorithms as a design tool for exon skipping oligonucleotides in duchenne muscular dystrophy
» Exon Skipping Quantification by qRT-PCR in Duchenne Muscular Dystrophy Patients Treated with the Antisense Oligomer Eteplirsen
» Implications for Cardiac Function Following Rescue of the Dystrophic Diaphragm in a Mouse Model of Duchenne Muscular Dystrophy
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum